Literature DB >> 17151465

Production of a polymer-forming fusion protein in Escerichia coli strain BL21.

Bun-Ichiro Ono1, Masashi Kubota, Hiroko Kimiduka, Hiroshi Kawaminami, Takamitsu Ueto, Shin Yokosawa, Masako Iseda, Yumiko Yamamoto, Yoshikazu Murakami, Sadaki Yokota.   

Abstract

In the course of studying [PSI(+)], a yeast prion, we found inadvertently that Escherichia coli strain BL21 overproducing a fusion protein, in which the prion-domain of Sup35 was connected to the C terminus of glutathione S-transferase, grew normally to the stationary phase and rapidly decreased in colony-forming ability thereafter. Evidence indicated that protein polymers consisting mainly of the fusion protein GST-Sup35NM (about 70% of the mass) and its N-terminal fragments were formed in extract prepared from the cells producing GST-Sup35NM. It was further found that cells of strain BL21 accumulated the protein polymers during prolonged cultivation. Based on these results, we contend that the initially observed defect in colony forming ability is the direct or indirect consequence of intracellular formation and accumulation of the protein polymers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151465     DOI: 10.1271/bbb.60047

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  2 in total

1.  Effects of mutations in yeast prion [PSI+] on amyloid toxicity manifested in Escherichia coli strain BL21.

Authors:  Bun-ichiro Ono; Hiroshi Kawaminami; Hironori Kobayashi; Masashi Kubota; Yoshikazu Murakami
Journal:  Prion       Date:  2008-01-13       Impact factor: 3.931

2.  Development an effective system to expression recombinant protein in E. coli via comparison and optimization of signal peptides: Expression of Pseudomonas fluorescens BJ-10 thermostable lipase as case study.

Authors:  Weiqing Zhang; Jing Lu; Shuwen Zhang; Lu Liu; Xiaoyang Pang; Jiaping Lv
Journal:  Microb Cell Fact       Date:  2018-03-28       Impact factor: 5.328

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.